Robot-assisted radical cystectomy: state of art and future perspectives
Bladder cancer (BC) remains one of the most common cancer worldwide. Radical cystectomy (RC) and pelvic lymph node dissection (PLND) with urinary diversion (UD) is still considered the gold standard treatment for non-metastatic muscle invasive bladder cancer (MIBC) and for recurrent non-muscle invas...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Asian Medical Press Ltd.(H.K.)
2019-12-01
|
Series: | Annals of Urologic Oncology |
Subjects: | |
Online Access: | http://auo.asmepress.com/articles/auo_2019017.html |
id |
doaj-40bfd7527ea04221962de5d567d84ad4 |
---|---|
record_format |
Article |
spelling |
doaj-40bfd7527ea04221962de5d567d84ad42020-11-25T01:45:55ZengAsian Medical Press Ltd.(H.K.)Annals of Urologic Oncology2617-77652617-77732019-12-01221710.32948/auo.2019.12.15Robot-assisted radical cystectomy: state of art and future perspectivesRiccardo 0Giuseppe 1MastroianniSimoneBladder cancer (BC) remains one of the most common cancer worldwide. Radical cystectomy (RC) and pelvic lymph node dissection (PLND) with urinary diversion (UD) is still considered the gold standard treatment for non-metastatic muscle invasive bladder cancer (MIBC) and for recurrent non-muscle invasive disease. The open approach remains the reference option of treatment for RC, even if robotic surgery is rapidly increasing. Nowadays, several studies have reported perioperative, functional and oncological outcomes of robot-assisted radical cystectomy (RARC), but data are still immature to compare both procedures. All the current randomized controlled trials (RCTs), did not prove any significant difference between open RC and RARC, underlining no superiority between both procedures. Therefore, RARC is still considered an investigational procedure. On the other hand, modern robotic surgical practice has been evolved by the introduction of innovative technologies. The technological progress is improving, in particular in robotic surgery, offering several future perspectives, such as the ICG technique. The aim of the review is to describe the state of art, and to outline future perspectives of RARC, in order to establish the role of robotic surgery in the complex field of radical cystectomy.http://auo.asmepress.com/articles/auo_2019017.htmlbladder cancerradical cystectomyrobot-assisted radical cystectomyurinary diversion |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Riccardo Giuseppe |
spellingShingle |
Riccardo Giuseppe Robot-assisted radical cystectomy: state of art and future perspectives Annals of Urologic Oncology bladder cancer radical cystectomy robot-assisted radical cystectomy urinary diversion |
author_facet |
Riccardo Giuseppe |
author_sort |
Riccardo |
title |
Robot-assisted radical cystectomy: state of art and future perspectives |
title_short |
Robot-assisted radical cystectomy: state of art and future perspectives |
title_full |
Robot-assisted radical cystectomy: state of art and future perspectives |
title_fullStr |
Robot-assisted radical cystectomy: state of art and future perspectives |
title_full_unstemmed |
Robot-assisted radical cystectomy: state of art and future perspectives |
title_sort |
robot-assisted radical cystectomy: state of art and future perspectives |
publisher |
Asian Medical Press Ltd.(H.K.) |
series |
Annals of Urologic Oncology |
issn |
2617-7765 2617-7773 |
publishDate |
2019-12-01 |
description |
Bladder cancer (BC) remains one of the most common cancer worldwide. Radical cystectomy (RC) and pelvic lymph node dissection (PLND) with urinary diversion (UD) is still considered the gold standard treatment for non-metastatic muscle invasive bladder cancer (MIBC) and for recurrent non-muscle invasive disease. The open approach remains the reference option of treatment for RC, even if robotic surgery is rapidly increasing. Nowadays, several studies have reported perioperative, functional and oncological outcomes of robot-assisted radical cystectomy (RARC), but data are still immature to compare both procedures. All the current randomized controlled trials (RCTs), did not prove any significant difference between open RC and RARC, underlining no superiority between both procedures. Therefore, RARC is still considered an investigational procedure. On the other hand, modern robotic surgical practice has been evolved by the introduction of innovative technologies. The technological progress is improving, in particular in robotic surgery, offering several future perspectives, such as the ICG technique. The aim of the review is to describe the state of art, and to outline future perspectives of RARC, in order to establish the role of robotic surgery in the complex field of radical cystectomy. |
topic |
bladder cancer radical cystectomy robot-assisted radical cystectomy urinary diversion |
url |
http://auo.asmepress.com/articles/auo_2019017.html |
work_keys_str_mv |
AT riccardo robotassistedradicalcystectomystateofartandfutureperspectives AT giuseppe robotassistedradicalcystectomystateofartandfutureperspectives |
_version_ |
1725021874223579136 |